Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD
NCT: NCT07442058 · NOT_YET_RECRUITING
Brief Summary
Impaired inhibitory response manifests clinically as increased impulsivity, which leads to poorer affective, cognitive, social, and occupational functioning. Neuropsychiatric disorders prevalent among Veterans, such as Attention Deficit/Hyperactivity Disorder (ADHD), are associated with poor inhibitory control. The mainstay of clinical treatment for ADHD is psychostimulants, yet these medications have significant risks, including dependence and numerous side effects. Thus, novel and non-pharmacological therapeutic strategies are needed. Intermittent Theta Burst Stimulation, a newer form of transcranial magnetic stimulation, has emerged as a promising tool for modulating inhibitory neuronal circuits. This research proposal will investigate the feasibility and acceptability of iTBS on inhibitory control and impulsivity through a randomized controlled trial to inform clinical observations. The long-term goal is to improve impulsivity, social and occupational functioning, and enhance the quality of life for Veterans.
Frequently Asked Questions
What is Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD?
Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD is a clinical trial registered under NCT07442058. Current status: NOT_YET_RECRUITING.
What is the status of NCT07442058?
The current status of NCT07442058 (Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD) is: NOT_YET_RECRUITING.
When did Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD start?
Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD started on 2026-10-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.